A urine-based Lyme disease test created by a team of George Mason University researchers could soon become available statewide after a recent clinical validation study confirmed that it meets sensitivity and absolute molecular specificity standards.
Since the start of the coronavirus pandemic, the National Science Foundation has awarded more than 800 Rapid Response Research (RAPID) grants designed to get researchers into the field and lab quicker than the traditional grant process.